Ersu Valuation Multiples

Ersu is valued at $10M as of September 2026, a 2.4x revenue multiple. In the last fiscal year, Ersu revenue was $3M and Ersu EBITDA was ($1M).

See full Ersu profile

Ersu Overview

About Ersu

Ersu Meyve ve Gida Sanayi AS is engaged in manufacturing concentrate and pulp juices in Turkey. The product offerings of the company include Pear juice concentrate, Quince juice concentrate, Blackberry juice concentrate, Apple juice concentrate, Pear puree, Strawberry puree, and Tomato Paste among others.


Founded

1968

HQ

Turkey

Employees

45

Financials (Last FY)

Revenue: $3M
EBITDA: ($1M)

EV

$8M

Valuation Multiples

Start free trial

Valuation Multiples for 15K+ Public Comps

AdidasAirbnbAmazonCiscoCoca-ColaDellDropboxIBMIntelMcDonaldsNikeNVIDIASamsungSpotifyTeslaToyota
Browse Valuation Multiples

Ersu Financials

Ersu reported last fiscal year revenue of $3M and negative EBITDA of ($1M).

In the same fiscal year, Ersu generated ($83K) in gross profit, ($1M) in EBITDA losses, and had net loss of ($3M).


Ersu P&L

In the most recent fiscal year, Ersu reported revenue of $3M and EBITDA of ($1M).

Ersu is unprofitable as of last fiscal year, with gross margin of (3%), EBITDA margin of (32%), and net margin of (76%).

See analyst estimates for Ersu
Last FY2025202620272028
Revenue$3M$3M
Gross Profit($83K)($83K)
Gross Margin(3%)(3%)
EBITDA($1M)($1M)
EBITDA Margin(32%)(32%)
EBIT Margin(21%)(21%)
Net Profit($3M)($3M)
Net Margin(76%)(76%)
Net Debt($118K)-

Financial data powered by Morningstar, Inc.

Ersu Stock Performance

Ersu has current market cap of $10M, and enterprise value of $8M.


Ersu's stock price is $0.29.

Ersu has an EPS (earnings per share) of $-0.07.

See more trading valuation data for Ersu
EVMarket CapPrice 1DPrice 1MPrice 3MPrice 12MEPS
$8M$10M-10.0%---$-0.07

Benchmark Trading Valuation Multiples by Industry

Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.

Start Free Trial

Ersu Valuation Multiples

Ersu trades at 2.4x EV/Revenue multiple, and (7.4x) EV/EBITDA.

See NTM and 2027E valuation multiples for Ersu

Ersu Financial Valuation Multiples

As of September 23, 2026, Ersu has market cap of $10M and EV of $8M.

Ersu has a P/E ratio of (4.1x).

Last FY2025202620272028
EV/Revenue2.4x2.4x
EV/EBITDA(7.4x)(7.4x)
EV/EBIT(11.7x)(11.7x)
EV/Gross Profit(95.8x)(95.8x)
P/E(4.1x)(4.1x)
EV/FCF(4.5x)(4.5x)

Multiples above and below 250x are considered non-meaningful (n/m). Valuation data powered by FactSet, Inc. and Morningstar, Inc.

Verified Ersu Valuation Multiples

Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.

FactSetMorningstar
Start Free Trial

Ersu Margins & Growth Rates

In the most recent fiscal year, Ersu reported gross margin of (3%), EBITDA margin of (32%), and net margin of (76%).

See estimated margins and future growth rates for Ersu

Ersu Margins

Last FY2025202720282029
Gross Margin(3%)(3%)
EBITDA Margin(32%)(32%)
EBIT Margin(21%)(21%)
Net Margin(76%)(76%)
FCF Margin(53%)(53%)

Data powered by FactSet, Inc. and Morningstar, Inc.

Ersu Operational KPIs

Ersu's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.0M for the same period.

Access forward-looking KPIs for Ersu
Last FY2025202620272028
Revenue per Employee$0.1M-
Opex per Employee$0.0M-
S&M Expenses to Revenue1%1%
G&A Expenses to Revenue3%3%
Opex to Revenue18%18%

Data powered by FactSet, Inc. and Morningstar, Inc.

Valuation Multiples Across 230+ Verticals

Ersu Competitors

Ersu competitors include Plasmapp Co, Laboratorio Farmaceutico, Civita Group, New Nordic Healthbrands, Cartier Saada, Willamette Valley, Kalve Coffee, Nuchev, M Food and Australian Dairy.

Most Ersu public comparables operate across Food & Beverages.

Last FYEV/RevenueEV/EBITDA
RevenueEBITDALast FYLTM2027ELast FYLTM2027E
Plasmapp Co$6M($3M)2.9x-(6.3x)-
Laboratorio Farmaceutico$11M$2M1.0x1.0x5.1x4.9x
Civita Group$13M$992K1.5x-19.2x-
New Nordic Healthbrands$59M$2M0.2x-7.8x-
Cartier Saada------
Willamette Valley$37M$3M2.2x-26.1x-
Kalve Coffee$6M$180K1.4x-48.7x-
Nuchev$18M($5M)0.6x0.6x(2.3x)-

This data is available for Pro users. Sign up to see all Ersu competitors and their valuation data.

Start Free Trial

Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples

Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.

Start Free Trial

About Ersu

When was Ersu founded?Ersu was founded in 1968.
Where is Ersu headquartered?Ersu is headquartered in Turkey.
How many employees does Ersu have?As of today, Ersu has over 45 employees.
Is Ersu publicly listed?Yes, Ersu is a public company listed on Borsa Istanbul.
What is the stock symbol of Ersu?Ersu trades under ERSU ticker.
When did Ersu go public?Ersu went public in 2000.
Who are competitors of Ersu?Ersu main competitors include Plasmapp Co, Laboratorio Farmaceutico, Civita Group, New Nordic Healthbrands, Cartier Saada, Willamette Valley, Kalve Coffee, Nuchev, M Food, Australian Dairy.
What is the current market cap of Ersu?Ersu's current market cap is $10M.
What is the current revenue of Ersu?Ersu's last fiscal year revenue is $3M.
What is the current EV/Revenue multiple of Ersu?Current revenue multiple of Ersu is 2.4x.
Is Ersu profitable?No, Ersu is not profitable.
How many companies Ersu has acquired to date?Ersu hasn't acquired any companies yet (or none have been disclosed publicly).
In how many companies Ersu has invested to date?Ersu hasn't invested in any companies yet (or none have been disclosed publicly).

See public comps similar to Ersu

Lists including Ersu

Start Your
Free Trial Today

Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.

Start Trial